Allergan CEO Saunders warms up to drug discovery

NEW YORK (Reuters) - Brenton Saunders, the whiz-kid pharmaceutical executive with a reputation for being wary of the costs of early-stage drug development, says he's open to new ideas from outside and is now warming up to investing in drug discovery if it makes sense for his company.

from Reuters: Top News http://ift.tt/1S29LqE
via IFTTT